News & events Upcoming events Medlab Middle East 2021 Jun 28, 2021 - Jul 1, 2021 Dubai , United Arab Emirates More info and meet us there Alzheimer's Association - AAIC 2021 Jul 26, 2021 - Jul 30, 2021 Denver (and online) , United States of America More info and meet us there CSF Society Meeting 2021 Sep 2, 2021 - Sep 3, 2021 Rome , Italy More info and meet us there See all upcoming events Latest news Fujirebio Europe launches iAMP® COVID-19 SANO Assay, a molecular detection assay that can be performed in saliva Jun 16, 2021 Gent, Belgium – June 16, 2021: Fujirebio Europe today announced the commercial launch of iAMP COVID-19 SANO (Saliva And Nasopharyngeal... Read more Statement on the impact of coronavirus disease Covid-19 on our operations Jan 19, 2021 The novel coronavirus disease Covid-19 first reported in late 2019 has spread worldwide. At Fujirebio Europe’s Belgian facilities, we are... Read more OHMX.bio and Fujirebio Europe receive grant of 720K EURO to incorporate third generation sequencing into clinical in vitro diagnostics platform Dec 8, 2020 Gent, Belgium, December 8, 2020 – OHMX.bio, a provider of cutting-edge “omics” solutions, and Fujirebio Europe announced today that they... Read more Fujirebio Europe and CENTOGENE enter partnership to provide rapid and high-quality preventive SARS-CoV-2 antigen testing Nov 9, 2020 Gent, Belgium, Cambridge, Mass., USA, and Rostock and Berlin, Germany – November 9, 2020: Fujirebio Europe and Centogene N.V. (Nasdaq: CNTG)... Read more Fujirebio Europe enters an agreement with ADx NeuroSciences for the commercialization of novel biomarkers Sep 4, 2020 Fujirebio Europe and ADx NeuroSciences announced today that they have concluded an agreement related to the development and... Read more Fujirebio Europe announces CE marking of the fully automated Lumipulse® G SARS-CoV-2 antigen assay and the rapid antigen device ESPLINE® SARS-CoV-2 Aug 11, 2020 With these new products Fujirebio further positions itself as a leading global provider of immunoassay testing solutions to the IVD industry... Read more Load More
Medlab Middle East 2021 Jun 28, 2021 - Jul 1, 2021 Dubai , United Arab Emirates More info and meet us there
Alzheimer's Association - AAIC 2021 Jul 26, 2021 - Jul 30, 2021 Denver (and online) , United States of America More info and meet us there
Fujirebio Europe launches iAMP® COVID-19 SANO Assay, a molecular detection assay that can be performed in saliva Jun 16, 2021 Gent, Belgium – June 16, 2021: Fujirebio Europe today announced the commercial launch of iAMP COVID-19 SANO (Saliva And Nasopharyngeal... Read more
Statement on the impact of coronavirus disease Covid-19 on our operations Jan 19, 2021 The novel coronavirus disease Covid-19 first reported in late 2019 has spread worldwide. At Fujirebio Europe’s Belgian facilities, we are... Read more
OHMX.bio and Fujirebio Europe receive grant of 720K EURO to incorporate third generation sequencing into clinical in vitro diagnostics platform Dec 8, 2020 Gent, Belgium, December 8, 2020 – OHMX.bio, a provider of cutting-edge “omics” solutions, and Fujirebio Europe announced today that they... Read more
Fujirebio Europe and CENTOGENE enter partnership to provide rapid and high-quality preventive SARS-CoV-2 antigen testing Nov 9, 2020 Gent, Belgium, Cambridge, Mass., USA, and Rostock and Berlin, Germany – November 9, 2020: Fujirebio Europe and Centogene N.V. (Nasdaq: CNTG)... Read more
Fujirebio Europe enters an agreement with ADx NeuroSciences for the commercialization of novel biomarkers Sep 4, 2020 Fujirebio Europe and ADx NeuroSciences announced today that they have concluded an agreement related to the development and... Read more
Fujirebio Europe announces CE marking of the fully automated Lumipulse® G SARS-CoV-2 antigen assay and the rapid antigen device ESPLINE® SARS-CoV-2 Aug 11, 2020 With these new products Fujirebio further positions itself as a leading global provider of immunoassay testing solutions to the IVD industry... Read more
